SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

DALLAS, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) NASDAQ:TIL, a biotechnology company building a portfolio of asset-focused subsidiaries to develop novel therapies for unmet medical needs, today reported its third quarter 2026 financial results and provided a corporate update.Re…

TIL

Related stories